NICE’s new Innovative Licensing and Access Pathway (ILAP) is a novel, streamlined process for new medicines in the United Kingdom. Himani Jaiswal from Clarivate reviews how to participate and what benefits this can bring for manufacturers aiming to get their treatments to market more quickly. Applying for the ILAP in the early product development […]
Close close